Ten-year follow-up of lung cancer patients with resected adenocarcinoma in situ or minimally invasive adenocarcinoma: Wedge resection is curative

医学 楔形切除术 腺癌 肺癌 外科 内科学 癌症 切除术
作者
Di Li,Chaoqiang Deng,Shengping Wang,Yuan Li,Yang Zhang,Haiquan Chen
出处
期刊:The Journal of Thoracic and Cardiovascular Surgery [American Association for Thoracic Surgery]
卷期号:164 (6): 1614-1622.e1 被引量:17
标识
DOI:10.1016/j.jtcvs.2022.06.017
摘要

Objective This study aimed to reveal the long-term outcomes of patients with lung cancer with adenocarcinoma in situ or minimally invasive adenocarcinoma after resection, in the context of the different surgical resection types. Methods Patients with lung adenocarcinoma who underwent resection between December 2007 and December 2012 were reviewed. Patients with pathological adenocarcinoma in situ or minimally invasive adenocarcinoma were enrolled. Postoperative survival and risk of developing second primary lung cancer were analyzed. Results After reevaluating the histological findings of 1696 patients with lung adenocarcinoma, we enrolled 53 with adenocarcinoma in situ and 72 with minimally invasive adenocarcinoma for analyses. Of all 125 patients with adenocarcinoma in situ/minimally invasive adenocarcinoma, 86 (68.8%) were female, 114 (91.2%) were nonsmokers, and most of them (78, 62.4%) underwent wedge resection. The median follow-up period after surgery was 111 months. The 10-year recurrence-free survivals of adenocarcinoma in situ and minimally invasive adenocarcinoma were all 100%, and the 10-year overall survivals of adenocarcinoma in situ and minimally invasive adenocarcinoma were 98.1% and 97.2%, respectively. There was no difference in 10-year recurrence-free survival between patients who underwent lobectomy and wedge resection. EGFR mutations were detected in 63.1% (41/65) of patients who underwent mutational analysis. The risks of developing second primary lung cancer for adenocarcinoma in situ and minimally invasive adenocarcinoma 10 years after resection were 8.4% and 4.3% (P = .298), respectively, and were not correlated with EGFR mutation status (P = .525). Conclusions Pathological adenocarcinoma in situ and minimally invasive adenocarcinoma have no recurrence during 10-year follow-up after resection, regardless of surgical procedure types. Surgery is curative for these patients, and wedge resection is the preferred surgical procedure for nodules in the proper location.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
zho应助njebcuiebvjc采纳,获得10
2秒前
2秒前
2秒前
3秒前
雨山发布了新的文献求助10
3秒前
3秒前
谢老板发布了新的文献求助10
4秒前
4秒前
威武雅容发布了新的文献求助10
5秒前
6秒前
liam发布了新的文献求助10
7秒前
7秒前
8秒前
虚心谷梦发布了新的文献求助10
8秒前
8秒前
8秒前
林睿易完成签到,获得积分20
9秒前
10秒前
chiynn发布了新的文献求助10
11秒前
11秒前
11秒前
能干雁凡发布了新的文献求助10
12秒前
wrr完成签到,获得积分0
12秒前
Lucas应助33采纳,获得10
12秒前
zc完成签到,获得积分10
13秒前
13秒前
虚心谷梦完成签到,获得积分10
14秒前
隐形曼青应助早点下班采纳,获得10
14秒前
14秒前
谢老板完成签到,获得积分10
14秒前
闪闪天晴发布了新的文献求助50
15秒前
15秒前
16秒前
小蘑菇应助孙一涵采纳,获得10
16秒前
16秒前
希望天下0贩的0应助阿玖采纳,获得10
16秒前
YZMING完成签到,获得积分10
17秒前
木一完成签到,获得积分10
18秒前
美丽嚓茶完成签到,获得积分10
18秒前
威武雅容完成签到,获得积分10
18秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Clinical Microbiology Procedures Handbook, Multi-Volume, 5th Edition 临床微生物学程序手册,多卷,第5版 2000
List of 1,091 Public Pension Profiles by Region 1621
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] | NHBS Field Guides & Natural History 1500
The Victim–Offender Overlap During the Global Pandemic: A Comparative Study Across Western and Non-Western Countries 1000
King Tyrant 720
T/CIET 1631—2025《构网型柔性直流输电技术应用指南》 500
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5589801
求助须知:如何正确求助?哪些是违规求助? 4674367
关于积分的说明 14793421
捐赠科研通 4629109
什么是DOI,文献DOI怎么找? 2532421
邀请新用户注册赠送积分活动 1501070
关于科研通互助平台的介绍 1468487